Thuja Capital β Full Portfolio
7 tracked investments Β· listed companies and verified rows first
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.
BiotechDeep TechHealthtech
Tjeerd Barf(Co-founder & CEO)inArwin Ridder(Co-founder & COO)inAd IJzerman(Co-founder & SAB Chair)inJason(Chief Scientific Officer)in
Co-investorsBioGeneration VenturesSeroba Life SciencesBGV
ATRO Medical is a Dutch clinical-stage orthopedic company developing the Artimis artificial meniscus implant (prosthesis) for patients with chronic knee pain after meniscectomy.
BiotechHealthtechMedical DevicesNijmegen, NL
Tony van Tienen(Founder)in
Co-investorsBOM
Cristal Therapeutics develops therapeutics in the life sciences sector.
BiotechDeep TechDigital HealthMedical DevicesUtrecht, NL
Dr. Cristianne Rijcken(Chief Scientific Officer and Founder)Dr. Joost Holthuis(Co-founder and former CEO)
Co-investorsBioGeneration VenturesChemelot VenturesBOMDroia Ventures
Tacalyx develops novel anticancer therapeutics that target Tumor-Associated Carbohydrate Antigens (TACAs), including antibody-drug conjugate programs.
BiotechDeep TechMedical DevicesBerlin, DE
Peter Seeberger(Co-founder (Prof. Dr.))Oren Moscovitz(CSO & Co-founder)
Co-investorsCreathor VenturesKurma PartnersBoehringer Ingelheim Venture Fundcoparion
Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology.
BiotechHealthtech
Ilan Ganot(CEO)inBenit Maru(CMO)Matthias Van Woensel(CSO)in
Co-investorsDroia VenturesFrazier Life SciencesNovartis Venture FundFrazier Healthcare PartnersRTW Investments L.P.
Mellon Medical manufactures a surgical instrument for abdominal wall closure featuring a double-pointed needle, ergonomic jaws, and atraumatic needle-suture combination.
HealthtechMedical DevicesRotterdam, NL
Co-investorsBOMBioGeneration Ventures
Santa Monica, US
Michael Einziger(Executive Officer, Director)Edna Coryell(Executive Officer, Director)Katherine Power(Director)Jessica Goldin(Executive Officer, Director)
BoardAnn Marie Simpson(Director)
Co-investors8VCDroia VenturesFrazier Life SciencesNovartis Venture FundRTW Investments L.P.The Column Group+1 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.


